title: Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?
authors.forename: George S
authors.initials: GS
authors.lastname: Cembrowski
authors.forename: David V
authors.initials: DV
authors.lastname: Tran
authors.forename: Linda
authors.initials: L
authors.lastname: Slater-Maclean
authors.forename: Dat
authors.initials: D
authors.lastname: Chin
authors.forename: R T Noel
authors.initials: RT
authors.lastname: Gibney
authors.forename: Michael
authors.initials: M
authors.lastname: Jacka
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D016638:Critical Illness; D006400:Hematocrit; D006801:Humans; D007362:Intensive Care Units; D008991:Monitoring, Physiologic / Q000295:instrumentation; D019095:Point-of-Care Systems
chemical_list: D001786:Blood Glucose